Ceera Investments’s Iovance Biotherapeutics IOVA Stock Holding History

Ceera Investments’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.9K	Hold	12,465	–	–	0.02%	101
2026 Q1	$43.8K	Buy	+12,465	New	+$39.9K	0.02%	93

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Ceera Investments's IOVA Position: Q2 2026 in Review

Ceera Investments held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 12,465 shares worth $51.9K. The position accounts for 0.02% of the portfolio, ranked #101.

Ceera Investments first reported a position in IOVA in Q1 2026 and has held it in 2 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Ceera Investments held 12,465 shares of Iovance Biotherapeutics worth $51.9K as of Q2 2026.
Ceera Investments left its Iovance Biotherapeutics share count unchanged in Q2 2026.
Iovance Biotherapeutics made up 0.02% of Ceera Investments's portfolio in Q2 2026, its #101 holding.
Ceera Investments first reported a position in Iovance Biotherapeutics in Q1 2026 and has held it in 2 quarters since.
292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Ceera Investments's 13F filing for Q2 2026, filed 6 Aug 2026.